J3C encouraged by Japan's "embracing" the use of CDISC

6 August 2006

The Japan CDISC Coordinating Committee (J3C) held its second annual CDISC Japan Interchange in Tokyo, July 11-13. The group, which is part of the Austin, Texas, USA-based Clinical Data Interchange Standards Consortium, is a non-profit organization, whose mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of health care. The CDISC's main project, the described data standard, bears the same name.

The J3C reports that all indicators show that "the interest and activities associated with CDISC standards have increased dramatically since last year's J3C event."

80% more attendees than in 2005

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight